SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-22-279707
Filing Date
2022-11-08
Accepted
2022-11-08 07:55:34
Documents
9

Document Format Files

Seq Description Document Type Size
1 S-3 d374206ds3.htm S-3 402533
2 EX-1.2 d374206dex12.htm EX-1.2 186690
3 EX-4.8 d374206dex48.htm EX-4.8 272738
4 EX-4.9 d374206dex49.htm EX-4.9 274821
5 EX-5.1 d374206dex51.htm EX-5.1 13531
6 EX-5.2 d374206dex52.htm EX-5.2 6705
7 EX-23.1 d374206dex231.htm EX-23.1 1813
8 EX-FILING FEES d374206dexfilingfees.htm EX-FILING FEES 78895
9 GRAPHIC g374206g10j01.jpg GRAPHIC 43353
  Complete submission text file 0001193125-22-279707.txt   1293925
Mailing Address 222 JACOBS STREET SUITE 200 CAMBRIDGE MA 02141
Business Address 222 JACOBS STREET SUITE 200 CAMBRIDGE MA 02141 844-304-2048
Cerevel Therapeutics Holdings, Inc. (Filer) CIK: 0001805387 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-268235 | Film No.: 221367294
SIC: 2834 Pharmaceutical Preparations